Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription 30.03.2026 1 Abdom Radiol (NY) 1 Acad Radiol 1 Am J Cancer Res 1 Am J Nurs 1 Apoptosis 1 Appl Biochem Biotechnol 1 Biol Direct 1 bioRxiv 1 BMC Public Health 1 BMC Womens Health 1 BMJ Open 1 Cancer Causes Control 1 Cancer Treat Res Commun 1 Clin Med Insights Oncol 1 Cytotechnology 1 Ecancermedicalscience 1 Eur J Cancer Prev 1 FEBS Open Bio 1 Front Cell Dev Biol 1 Front Cell Infect Microbiol 1 Front Genet 1 Front Immunol 1 Front Med (Lausanne) 4 Front Oncol 1 Hum Vaccin Immunother 1 Immunol Res 2 Int J Infect Dis 1 Int J Nanomedicine 1 Int J Public Health 1 Int Urogynecol J 3 J Gynecol Oncol 1 J Minim Invasive Gynecol 1 J Natl Cancer Inst 1 J Oncol Pharm Pract 1 J Pain Res 1 Lancet Reg Health Am 1 Life Sci 1 Mod Rheumatol Case Rep 1 Mol Carcinog 1 Mol Oncol 1 Nanomedicine 2 Nursing 2 PLoS One 1 Popul Health Manag 2 Prev Med 1 Rev Argent Microbiol 2 Schizophr Bull 1 Sci Adv 1 Sci Prog 3 Sci Rep 1 Tissue Cell 1 Zhonghua Fu Chan Ke Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Abdom Radiol (NY)

1. MAHDAVI SABET F, Forghani S, Shahsavand A, Kharaghani M, et al
   Diagnostic and clinical utility of ultrasound elastography for uterine cervical neoplasms-a comprehensive systematic review and meta-analysis.
   Abdom Radiol (NY). 2026;51:2030-2043.
   PubMed         Abstract available
   
   

   
   Acad Radiol

2. LI T, Ma J, Pang C, Wang Y, et al
   Head-to-head Comparison of Fibroblast Activation Protein Inhibitors and (18)F-fluorodeoxyglucose in Cervical Cancer: A Systematic Review and Meta-analysis.
   Acad Radiol. 2026 Mar 24:S1076-6332(26)00170-4. doi: 10.1016/j.acra.2026.
   PubMed         Abstract available
   
   

   
   Am J Cancer Res

3. HE Z, Lai J, Lin W, Lu K, et al
   Prognostic value of the lactate dehydrogenase-to-albumin ratio (LAR) combined with clinicopathological indicators for predicting outcomes in locally advanced cervical cancer undergoing concurrent chemoradiotherapy: a retrospective cohort study and nom
   Am J Cancer Res. 2026;16:470-495.
   PubMed         Abstract available
   
   

   
   Am J Nurs

4. ROSENBERG K
   One dose of HPV vaccine is noninferior to two doses.
   Am J Nurs. 2026;126:62.
   PubMed         Abstract available
   
   

   
   Apoptosis

5. ANTONY EDWIN RODRIGUES F, Krishnan D, Abbas HH, Raj MJM, et al
   Transcriptome sequencing (RNA-Seq) reveals non-coding pseudogene CDC27P9 role in cervical cancer.
   Apoptosis. 2026;31:111.
   PubMed         Abstract available
   
   

   
   Appl Biochem Biotechnol

6. SU Y, Zhang J, Wu H, Zhang Y, et al
   NCBP2 Regulates PGAM5-Mediated Mitophagy Via KIF23 Alternative Splicing To Promote Cervical Cancer ProgressionRun Title: NCBP2 Promotes Cervical Cancer Via Mitophagy.
   Appl Biochem Biotechnol. 2026 Mar 24. doi: 10.1007/s12010-026-05607.
   PubMed         Abstract available
   
   

   
   Biol Direct

7. LI J, Li F, Meng X, Yang Z, et al
   FAM83D facilitates EMT and metastasis of cervical cancer via interaction with GSK3beta and inactivation of GSK3beta/stabilization of Snail signaling.
   Biol Direct. 2026 Mar 25. doi: 10.1186/s13062-026-00761.
   PubMed        
   
   

   
   bioRxiv

8. PIERSON RN, Gupta SA, Zhang M, Kaiser LC, et al
   QUANTIFYING GLYCOGEN AND LIPID DROPLET SYNTHESIS IN OVARIAN AND CERVICAL CANCER CELLS USING DEUTERATED RAMAN PROBES WITH STIMULATED RAMAN SCATTERING MICROSCOPY.
   bioRxiv [Preprint]. 2026 Mar 18:2026.03.16.712189.
   PubMed         Abstract available
   
   

   
   BMC Public Health

9. ASARE M, Sam-Agudu NA, Cudjoe O, Frueh E, et al
   HOme-based self-sampling for cervical cancer prevention education among women living with HIV in Ghana (HOPE-inG): study protocol for a cluster-randomized type 2 hybrid effectiveness implementation trial.
   BMC Public Health. 2026 Mar 27. doi: 10.1186/s12889-026-26505.
   PubMed         Abstract available
   
   

   
   BMC Womens Health

10. PAUDEL YR, Xu L, Onobrakpor SI, Dampf H, et al
    Reduced age-wise disparity in estimated cervical cancer screening participation rates after applying hysterectomy correction: a population-based cross-sectional study.
    BMC Womens Health. 2026 Mar 26. doi: 10.1186/s12905-026-04414.
    PubMed        
    
    

    
    BMJ Open

11. SIGOVANA K, Nomatshila SC, Chitha W, Mabunda SA, et al
    Protocol for exploring health promoter-led mental wellness initiatives for early prevention, screening and quality of life in patients with cervical cancer of rural Eastern Cape, South Africa: a mixed-methods study.
    BMJ Open. 2026;16:e104827.
    PubMed         Abstract available
    
    

    
    Cancer Causes Control

12. WU R, Kalima M, Msadabwe S, Mwaba C, et al
    Changes in cervical cancer stage at diagnosis in Zambia over 15 years.
    Cancer Causes Control. 2026;37:65.
    PubMed         Abstract available
    
    

    
    Cancer Treat Res Commun

13. HASE EA, Ferreira HB, Peres SV, Sadalla JC, et al
    Cervical cancer during pregnancy: Management and maternal and perinatal outcomes.
    Cancer Treat Res Commun. 2026;47:101185.
    PubMed         Abstract available
    
    

    
    Clin Med Insights Oncol

14. SAPKOTA S, Pandit S, Bhandari J, Adhikari A, et al
    Stage Migration and Validity of the International Federation of Gynecology and Obstetrics (FIGO) 2018 Staging System for Cervical Cancer: A Retrospective Cohort Study From a Tertiary Cancer Center in Nepal.
    Clin Med Insights Oncol. 2026;20:11795549261434986.
    PubMed         Abstract available
    
    

    
    Cytotechnology

15. WANG L, Zhang M, Li Y, Lei R, et al
    Serum PLAC1 levels for differential diagnosis between cervical intraepithelial neoplasia and invasive cervical cancer: a prospective observational study.
    Cytotechnology. 2026;78:70.
    PubMed         Abstract available
    
    

    
    Ecancermedicalscience

16. MOHAMAD B, Saifo M
    Real-world evaluation of bevacizumab plus platinum and paclitaxel for advanced cervical cancer: a single-arm study from Syria.
    Ecancermedicalscience. 2026;20:2066.
    PubMed         Abstract available
    
    

    
    Eur J Cancer Prev

17. CAIA C, De Maria F, Sopracordevole F, Ciavattini A, et al
    Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia.
    Eur J Cancer Prev. 2026;35:243-249.
    PubMed         Abstract available
    
    

    
    FEBS Open Bio

18. MALFATTI MC, Gualandi N, Tell G, Antoniali G, et al
    The cooperative regulation of miR-221 by APE1 and AUF1 impacts p27(Kip1) defining a miR signature relevant for cervical cancer.
    FEBS Open Bio. 2026 Mar 23. doi: 10.1002/2211-5463.70190.
    PubMed         Abstract available
    
    

    
    Front Cell Dev Biol

19. LI W, Ran R, Li J
    Single-cell and multi-omics analyses identify CAMP-associated neutrophil remodeling during radiochemotherapy in cervical cancer.
    Front Cell Dev Biol. 2026;14:1773562.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

20. JI L, Wu J, Zhou Y, Pu X, et al
    A prospective cohort study on the association between cervical microenvironmental factors and the efficacy of treating high-risk human papillomavirus infection comorbid with cervical diseases.
    Front Cell Infect Microbiol. 2026;16:1734088.
    PubMed         Abstract available
    
    

    
    Front Genet

21. WANG M, Cao Y, Zhu M, Zhao P, et al
    An auxiliary diagnosis model for the pathological classification of cervical cancer based on radiomics biomarkers.
    Front Genet. 2026;17:1685927.
    PubMed         Abstract available
    
    

    
    Front Immunol

22. ZHOU L, Sun C, Diao P, Wang J, et al
    Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.
    Front Immunol. 2026;17:1780791.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

23. XU B, Liu J, Li H, Zhang T, et al
    Concordance and acceptability of a novel human papillomavirus self-collection tool for cervical cancer screening in economically developed regions: a prospective cohort study in Shanghai, China.
    Front Med (Lausanne). 2026;13:1760186.
    PubMed         Abstract available
    
    

    
    Front Oncol

24. LI Y, Liu Z, Jin H
    Mechanism of N6-methyladenosine (m6A)-mediated upregulation of LINC00958 in the growth of cervical cancer.
    Front Oncol. 2026;16:1663904.
    PubMed         Abstract available
    
    
25. YANG Q, Bai D, Bao L, Liang L, et al
    Case Report: A case of right ventricular metastasis from cervical cancer presenting with thrombocytopenia: the role of echocardiography and myocardial contrast echocardiography.
    Front Oncol. 2026;16:1774949.
    PubMed         Abstract available
    
    
26. SAVAS LS, Heredia NI, Huyan Y, Coan S, et al
    A randomized controlled trial to evaluate an adapted community health worker-delivered breast and cervical cancer screening education and navigation intervention for underserved Latina adults.
    Front Oncol. 2026;16:1687113.
    PubMed         Abstract available
    
    
27. ABUDOUKADE A, Hong S, Jiang M, Yin D, et al
    Predictive value of the systemic immune-inflammation index combined with the prognostic nutritional index for postoperative recurrence in early-stage cervical cancer: evidence from a multicenter cohort study.
    Front Oncol. 2026;16:1792373.
    PubMed         Abstract available
    
    

    
    Hum Vaccin Immunother

28. MAO Y, Xing N, Sun W, Bao X, et al
    Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-beta bifunctional fusion protein in recurrent cervical cancer.
    Hum Vaccin Immunother. 2026;22:2647560.
    PubMed         Abstract available
    
    

    
    Immunol Res

29. HAN C, Zhao Y, Yang X, Sun F, et al
    Integrated analysis and functional validation of PEG3, SYNPO2, and DCN as regulators of tumor suppression and cellular stress in cervical cancer.
    Immunol Res. 2026;74:31.
    PubMed        
    
    

    
    Int J Infect Dis

30. KAMOLRATANAKUL S, Niyom SL, Isarankura N, Ruengprasertkit C, et al
    Long-term effectiveness of at least one dose of human papillomavirus vaccine in adolescents: A test-negative case-control study.
    Int J Infect Dis. 2026;165:108489.
    PubMed         Abstract available
    
    
31. LIU Y, Dai W, Du H, Jiang X, et al
    Evidence for triaging HPV-positive women using viral load: data from two large cohort-screening projects in different regions of China.
    Int J Infect Dis. 2026;165:108462.
    PubMed         Abstract available
    
    

    
    Int J Nanomedicine

32. QIU Y, Hu C, Zhao S, Chen D, et al
    ROS-Responsive Nano-Encapsulated Selenium Targeting Cervical Cancer Cell via PI3K/AKT Signaling Pathway.
    Int J Nanomedicine. 2026;21:558115.
    PubMed         Abstract available
    
    

    
    Int J Public Health

33. SHAMSUNDER S, Digumarti L, Nayak B, Dasari V, et al
    Bringing Cervical Cancer Screening Closer to Women: Feasibility of Artificial Intelligence and Remote Assessment in Primary Health Care.
    Int J Public Health. 2026;71:1609094.
    PubMed         Abstract available
    
    

    
    Int Urogynecol J

34. ANDRADE MB, Pilger TL, Candido Dos Reis FJ
    Prevalence of Pelvic Floor Dysfunction in Women with Cervical Cancer: A Cross-Sectional Study.
    Int Urogynecol J. 2026 Mar 24. doi: 10.1007/s00192-026-06582.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

35. LIM H, Kim SI, Min KJ, Lee JK, et al
    Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations.
    J Gynecol Oncol. 2026;37:e71.
    PubMed         Abstract available
    
    
36. TANTITAMIT T, Vasuratna A, Khemapech N, Havanond P, et al
    Cost-effectiveness of HPV catch-up vaccination program in women aged 13-24 years in a middle income country.
    J Gynecol Oncol. 2026;37:e27.
    PubMed         Abstract available
    
    
37. KANAO H, Tamate M, Matsuura M, Nagao S, et al
    Relationship between the lateral dissection lines of various radical hysterectomies and anatomical structures in the female pelvis: an educational video from the Sapporo Cadaver Surgical Workshop.
    J Gynecol Oncol. 2026;37:e21.
    PubMed         Abstract available
    
    

    
    J Minim Invasive Gynecol

38. CHAULEUR C, Bourrely T
    Robotic Single Port Retroperitoneal Para-aortic Lymphadenectomy, Staging for Advanced Squamous Cell Carcinoma of the Cervix.
    J Minim Invasive Gynecol. 2026;33:374.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

39. GOPALANI SV, Qin J, Wu M, Senkomago V, et al
    Declines in cervical cancer incidence among young women in the United States.
    J Natl Cancer Inst. 2026 Mar 25:djaf375. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Oncol Pharm Pract

40. SAMAILA A, Isah A, Biambo AA, Usman N, et al
    Development and reliability testing of a cervical cancer patients knowledge and practice of self-care management of treatment-related adverse events questionnaire.
    J Oncol Pharm Pract. 2026;32:238-243.
    PubMed         Abstract available
    
    

    
    J Pain Res

41. LU C, Chen N, Sun H, Wang C, et al
    Effect of Electroacupuncture on Postoperative Urinary Retention After Radical Hysterectomy for Cervical Cancer: Study Protocol for A Randomized Controlled Trial.
    J Pain Res. 2026;19:598960.
    PubMed         Abstract available
    
    

    
    Lancet Reg Health Am

42. BENITEZ MAJANO S, Katz N, Urrutia S, Caixeta R, et al
    Accelerating the elimination of cervical cancer: cross-sectional examination of cancer prevention and control in Latin America and the Caribbean.
    Lancet Reg Health Am. 2026;55:101398.
    PubMed         Abstract available
    
    

    
    Life Sci

43. MA X, Jiang F, Chen Y, Cao Y, et al
    RNF2 facilitates the progression of cervical cancer through the degradation of LATS1.
    Life Sci. 2026 Mar 20:124340. doi: 10.1016/j.lfs.2026.124340.
    PubMed         Abstract available
    
    

    
    Mod Rheumatol Case Rep

44. MECOLI CA, Viswanathan AN, Rosen A, Casciola-Rosen L, et al
    Parallel course of calcinosis and cancer in a patient with anti-NXP2-positive dermatomyositis: A case report.
    Mod Rheumatol Case Rep. 2026;10:rxag016.
    PubMed         Abstract available
    
    

    
    Mol Carcinog

45. YANG H, Li Y, Xiao Z, Kuang M, et al
    Mechanism of HAND2 Regulating Glycolytic Metabolism and Metastasis Through TLR4/NOX2/DUOX2 Signaling Axis in Cervical Cancer.
    Mol Carcinog. 2026 Mar 23. doi: 10.1002/mc.70082.
    PubMed         Abstract available
    
    

    
    Mol Oncol

46. PUNZIANO C, Minopoli G, Romano S, Marrone L, et al
    Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation.
    Mol Oncol. 2026 Mar 25. doi: 10.1002/1878-0261.70216.
    PubMed         Abstract available
    
    

    
    Nanomedicine

47. ALI AA, McCrudden CM, McCaffrey J, McBride JW, et al
    Corrigendum to "DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles" [Nanomed Nanotechnol Biol Med 10.1016/j.nano.2016.11.019 [pubmed: 27979747 issn: 1549-9634]].
    Nanomedicine. 2026 Mar 25:102932. doi: 10.1016/j.nano.2026.102932.
    PubMed        
    
    

    
    Nursing

48. PULLEN RL JR, Ritchie S
    A clinical review of cervical cancer.
    Nursing. 2026;56:17-27.
    PubMed         Abstract available
    
    
49. 
    A clinical review of cervical cancer.
    Nursing. 2026;56:27-28.
    PubMed        
    
    

    
    PLoS One

50. DAY S, Harries J, Sawula B, Payne A, et al
    Navigating cancer: Insights from patient journey mapping.
    PLoS One. 2026;21:e0327113.
    PubMed         Abstract available
    
    
51. YAN K, Yang G, Yan L, Wu L, et al
    Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database.
    PLoS One. 2026;21:e0345286.
    PubMed         Abstract available
    
    

    
    Popul Health Manag

52. SONODA K, Chrusciel T, Gebauer SC, Bello JK, et al
    Cervical Cancer and Sexually Transmitted Infections Screening Among Individuals with a Substance Use Disorder: A Retrospective Cohort Study.
    Popul Health Manag. 2026 Mar 24:19427891261434371.
    PubMed         Abstract available
    
    

    
    Prev Med

53. HERRERA DJ, Huber L, Ferrari A, Van Hal G, et al
    Barriers to and facilitators of cancer prevention services for transgender and gender-diverse people: A systematic review.
    Prev Med. 2026;206:108544.
    PubMed         Abstract available
    
    
54. LIM JH, Yeap LL, Saw PS, Ng KY, et al
    Determinants of cervical cancer screening in Southeast Asia: A systematic review using the COM-B model and the theoretical domains framework.
    Prev Med. 2026 Mar 24:108564. doi: 10.1016/j.ypmed.2026.108564.
    PubMed         Abstract available
    
    

    
    Rev Argent Microbiol

55. GOMEZ CHEREY JF, Noemi Payalef S, Chen X, Paula Reyes A, et al
    Prevalence of hr-HPV types and their association with bacterial vaginosis, yeasts and trichomoniasis in Argentine women.
    Rev Argent Microbiol. 2026;58:206-217.
    PubMed         Abstract available
    
    

    
    Schizophr Bull

56. PILLAI S, Wynter K, Galbally M
    A Systematic Review of Women's Cancer Screening and Mortality in Women with Severe Mental Illness.
    Schizophr Bull. 2026;52:sbaf254.
    PubMed         Abstract available
    
    
57. LIN CC, Chuang CC, Wang CY, Cheng SH, et al
    The Cancer Screening Disparity among Women With Schizophrenia by Co-occurring Chronic Physical Illness Status: A Nationwide Cohort Study in Taiwan.
    Schizophr Bull. 2026;52:sbaf206.
    PubMed         Abstract available
    
    

    
    Sci Adv

58. WENG Z, Huang W, Wu Y, Xiu X, et al
    Machine learning-directed massively parallel programmable nucleic acid amplification.
    Sci Adv. 2026;12:eaec9175.
    PubMed         Abstract available
    
    

    
    Sci Prog

59. CHEN C, Guo L, Li S, Sun J, et al
    Predicting complete response to concurrent chemoradiotherapy in locally advanced cervical squamous cell carcinoma using multi-sequence MRI data and a 2.5D deep learning algorithm integrated with crossformer model.
    Sci Prog. 2026;109:368504261437172.
    PubMed         Abstract available
    
    

    
    Sci Rep

60. HAGOS MT, Suutala A, Bychkov D, Kucukel H, et al
    Validation of conformal prediction in cervical atypia classification.
    Sci Rep. 2026;16:9649.
    PubMed         Abstract available
    
    
61. SAKTHIVEL M, Ramalingam A, Chadwick J, Kriina M, et al
    Cervical cancer screening coverage and care cascade in Tamil Nadu, India, based on a community-based cross-sectional survey.
    Sci Rep. 2026 Mar 26. doi: 10.1038/s41598-026-45005.
    PubMed        
    
    
62. BILGAIYAN S, Swain A, Das S, Medha, et al
    Advanced analysis and detection of cervical cancer using NASNetLarge.
    Sci Rep. 2026 Mar 24. doi: 10.1038/s41598-026-38341.
    PubMed        
    
    

    
    Tissue Cell

63. WANG J, Li Z, He Y, Chu Y, et al
    Corrigendum to "Targeting Siglec-15 mediates mitochondrial retrograde regulation of cervical cancer development" [Tissue Cell 93 (2025) 102713].
    Tissue Cell. 2026 Mar 20:103478. doi: 10.1016/j.tice.2026.103478.
    PubMed        
    
    

    
    Zhonghua Fu Chan Ke Za Zhi

64. XIAO JJ, Cong Q, Sui L
    [Correlation study of blood lipid indexes and body mass index with clinical characteristics of cervical squamous cell carcinoma].
    Zhonghua Fu Chan Ke Za Zhi. 2026;61:236-245.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum